U.S. Physical Therapy, Inc. (NYSE:USPH) Position Trimmed by Ameriprise Financial Inc.

Ameriprise Financial Inc. decreased its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 16.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 114,178 shares of the company's stock after selling 22,550 shares during the period. Ameriprise Financial Inc. owned about 0.76% of U.S. Physical Therapy worth $10,129,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CBIZ Investment Advisory Services LLC lifted its stake in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after acquiring an additional 122 shares in the last quarter. Venturi Wealth Management LLC raised its position in shares of U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares in the last quarter. Pacer Advisors Inc. acquired a new position in shares of U.S. Physical Therapy in the 4th quarter valued at approximately $113,000. Aquatic Capital Management LLC boosted its stake in shares of U.S. Physical Therapy by 18.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after buying an additional 198 shares during the last quarter. Finally, Mutual of America Capital Management LLC acquired a new stake in shares of U.S. Physical Therapy during the fourth quarter worth approximately $203,000.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at approximately $588,564.48. This represents a 19.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.00% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

USPH has been the topic of several recent analyst reports. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. decreased their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Finally, Barrington Research reduced their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Stock Performance

USPH stock traded down $1.44 during midday trading on Friday, reaching $73.96. The company had a trading volume of 107,229 shares, compared to its average volume of 111,709. The firm has a market capitalization of $1.12 billion, a PE ratio of 78.68, a P/E/G ratio of 3.54 and a beta of 1.44. The stock has a 50 day moving average price of $71.89 and a 200 day moving average price of $83.20. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $102.89. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.51 EPS. Analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.43%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.